Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)

Withdrawn before enrolling · Phase 2 · Has a placebo group

Conditions studied: Multiple Sclerosis

In brief

The purpose of this study is to evaluate whether the use of ACTH in addition to Avonex is effective in the treatment of relapsing remitting multiple sclerosis.

Key facts

Study ID
NCT00986960
Run by
University at Buffalo
People needed
0
Starts
2009-12-01
Expected to finish
2010-12-01
Last updated by the study team
2021-01-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.